In AD, the therapeutic potential of neurotransmitter inhibitors has been well established, such as acetylcholinesterase inhibitors (AChEI) donepezil, rivastigmine, memantine and galantamine [9]. This evidence concerns the gene ACHE and Alzheimer disease.